The UK cancer diagnostics company, Oncimmune Ltd, has appointed Meinhard Schmidt as its non-executive chairman to help commercialise a test for lung cancer and launch other new products. Mr Schmidt has been an executive at Roche Diagnostics as well as a senior vice president at Lab Diagnostics. He currently serves as board director at Sphere Medical Plc, valuationLAB AG, CeQur AG and chairs Promimic AB,
a Swedish biomaterials company.
Oncimmune announced the appointment on 14 September 2015.
Copyright 2015 Evernow Publishing Ltd